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Abstract
Background and Aims—Coronary artery disease (CAD) is progressive, classified by stages of 
severity. Alterations in Ca2+ regulation within coronary smooth muscle (CSM) cells in metabolic 
syndrome (MetS) have been observed, but there is a lack of data in relatively early (mild) and late 
(severe) stages of CAD. The current study examined alterations in CSM Ca2+ regulation at several 
time points during CAD progression.
Methods—MetS was induced by feeding an excess calorie atherogenic diet for 6, 9, or 12 
months and compared to age-matched lean controls. CAD was measured with intravascular 
ultrasound (IVUS). Intracellular Ca2+ was assessed with fura-2.
Results—IVUS revealed that the extent of atherosclerotic CAD correlated with the duration on 
atherogenic diet. Fura-2 imaging of intracellular Ca2+ in CSM cells revealed heightened Ca2+ 
signaling at 9 months on diet, compared to 6 and 12 months, and to age-matched lean controls. 
Isolated coronary artery rings from swine fed for 9 months followed the same pattern, developing 
greater tension to depolarization, compared to 6 and 12 months (6 months= 1.8±0.6 g, 9 months= 
5.0±1.0 g, 12 months= 0.7±0.1 g). CSM in severe atherosclerotic plaques showed dampened Ca2+ 
regulation and decreased proliferation compared to CSM from the wall.
Conclusions—These CSM Ca2+ regulation data from several time points in CAD progression 
and severity help to resolve the controversy regarding up- vs. down-regulation of CSM Ca2+ 
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regulation in previous reports. These data are consistent with the hypothesis that alterations in 
sarcoplasmic reticulum Ca2+ contribute to progression of atherosclerotic CAD in MetS.
Keywords
Calcium regulation; smooth muscle phenotype; proliferation; Ossabaw swine
Introduction
Obesity affects more than one-third of adults in the United States1. The human propensity 
for obesity has been attributed to a “thrifty genotype”2. This “thrifty genotype” was adaptive 
during the early stages of human evolution, when humans were easily affected by the “feast 
or famine” environment associated with changing seasons and a lack of modern food 
preservation and storage. Now, a consistent and abundant food supply, coupled with a 
sedentary lifestyle, has propelled the obesity epidemic, resulting in the coining of such terms 
as “obesogenic environment”3 and tongue-in-cheek references to a new species with the 
name “Homo sedentarius”4. Obesity often appears in connection with the metabolic 
syndrome (MetS), which is classically defined as the clustering of three or more of the 
following risk factors: central obesity, hypertension, dyslipidemia, insulin resistance, and 
glucose intolerance5. Together, obesity and MetS double the risk of coronary artery disease 
(CAD), the leading killer of Americans6.
CAD is a progressive disease with stages typically classified according to the Stary 
classification system7. Early, clinically insignificant neointimal thickening due to lipid 
deposition in the artery wall worsens with increasing lipid and inflammatory cell 
infiltration8, 9. Further progression involves recruitment of coronary smooth muscle (CSM) 
cells from the media into the growing plaque. Such mobilization is accompanied by a shift in 
CSM phenotype from healthy, contractile CSM cells to synthetic, proliferative CSM cells10, 
whose secretory capabilities result in the deposition of collagen and other fibers into the 
developing lesion. The presence of CSM cells in the atherosclerotic plaque stabilizes the 
early lesion. As atherosclerotic CAD progresses, however, increased apoptosis and 
accumulation of lipids and cellular debris within the plaque results in thinning of the fibrous 
cap surrounding the lesion. This thinning of the fibrous cap may lead to rupture and 
thrombosis, often resulting in myocardial infarction and sudden cardiac death.
Ca2+ is a ubiquitous second messenger known to be involved in smooth muscle 
contraction10, 11, proliferation10, 12–14, migration15, 16, and gene transcription17, 18. 
Therefore, alteration in CSM Ca2+ regulation in CAD is an important area of study. 
Alterations in many Ca2+ transporters, including voltage-gated Ca2+ channels19, 20, sarco-
endoplasmic reticulum Ca2+ ATPases19, 21, 22, transient receptor potential channels23, 
plasma membrane Ca2+ ATPases19, and Na+/Ca2+ exchangers19, have been described in 
CAD24. However, there is a paucity of data regarding time-dependent changes in CSM Ca2+ 
handling in the setting of obesity/MetS. This study utilized the well-characterized Ossabaw 
miniature swine model of MetS and CAD22, 23, 25–28 to examine the changes in CSM Ca2+ 
regulation during obesity-induced CAD progression, providing a much needed longitudinal 
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assessment of Ca2+ regulation over time and with increasing severity. Further, we examined 
differences in Ca2+ regulation in CSM harvested specifically from plaque vs. vascular wall.
Materials and methods
Animal care and experimental groups
All experimental procedures involving animals were approved by the Institutional Animal 
Care and Use Committee at Indiana University School of Medicine with the 
recommendations outlined by the National Research Council and the American Veterinary 
Medical Association Panel on Euthanasia29, 30. Six month old Ossabaw miniature swine 
were fed 1 kg of an excess-calorie atherogenic diet daily for 6 (n=6), 9 (n=7), or 12 (n=9) 
months in the repeat cross-sectional study (Figs. 1 and 2). The 6 and 9 month time points 
were considered “early” and the 12 month time point “late” CAD for comparison to Lean 
healthy pigs. For comparison, an additional subset of Ossabaw miniature swine were fed the 
same excess-calorie atherogenic diet above for 11 months to provide coronary arteries for 
comparison of CSM in “mild CAD” and “severe CAD” defined as arteries with less than 
30% and greater than 30% plaque burden, respectively, as assessed by IVUS (Fig. 3–5). 
Plaque vs. vascular wall components were dissected from the same artery segments in severe 
CAD to compare CSM properties (Fig. 4). Lean control swine for this dataset (n=6) were fed 
the standard diet mentioned above.
Metabolic phenotyping
Final body weights and blood were obtained at time of sacrifice for lipid analysis (ANTECH 
Diagnostics, Fishers, IN).
Intravascular ultrasound (IVUS) for quantification of coronary artery disease
Swine were anesthetized and intravascular ultrasound was performed as described 
previously22, 23, 31, 32.
Still frame IVUS pullback images were obtained offline at 1 mm intervals (Fig. 1). Percent 
plaque burden measures were obtained using Image J software (1.48v, National Institutes of 
Health, USA).
Fluorescent imaging for assessment of CSM intracellular Ca2+ signaling from freshly 
harvested coronary arteries
CSM cells from Ossabaw swine were enzymatically isolated from freshly dissected coronary 
arteries and loaded with fura-2 AM (2.5 mmol/l Molecular Probes, Life Technologies, 
Eugene, OR) as previously described 19, 22, 23, 33.
Isometric tension studies for functional assessment of freshly harvested coronary arteries
Isometric tension was examined in isolated coronary artery rings (2–4 mm in length) as 
described previously34.
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Isolation of atherosclerotic plaques from coronary arteries with severe CAD
Following IVUS and sacrifice, coronary arteries were excised and cleaned of adherent tissue. 
Arteries were segmented and opened longitudinally. Artery segments with plaque burden 
greater than 30% as measured by IVUS were selected and labeled as “severe CAD” (n=5). 
Plaques such as those labeled as intima (I) in Fig. 4I “Severe CAD” histology were trimmed 
away from the artery wall and placed in conical tubes containing the same collagenase 
solution previously described for isolation of CSM cells from the coronary artery wall 
(media)19, 22, 23, 33. The plaque cell population was then isolated through a series of 
enzymatic washes. Plaque cells were loaded with fura-2/AM for 45 minutes, washed, and 
placed on ice prior to being imaged as described above.
Histology
Coronary artery segments (2–4 mm in length) were placed in 10% phosphate-buffered 
formalin for 24–48 hours, and then transferred to 70% ethanol. Histology was performed in 
the Department of Anatomy and Cell Biology at Indiana University School of Medicine 
(Indianapolis, IN).
Immunohistochemistry
Coronary artery segments embedded in paraffin (described above) were transported the 
Department of Pathology at Indiana University School of Medicine and were processed as 
previously described32. Immunostaining was performed using Ki-67 as a proliferation 
marker. Images were captured using a LEICA DM 300 inverted microscope and analyzed 
with ImageJ software.
Statistical analysis
Statistical analysis was performed using GraphPad Prism 5.0 (San Diego, CA). One-way 
analysis of variance (ANOVA) or two-way ANOVA with Bonferroni post hoc analysis was 
performed. Data are represented as mean±SEM. p <0.05 was considered statistically 
significant.
RESULTS
Metabolic cCharacteristics
Swine fed an excess-calorie atherogenic diet developed MetS as indicated by increased body 
weight, hypertension, and elevated total cholesterol and triglycerides, (see Table 1 in 
associated Data in Brief article35). Plasma triglycerides and total cholesterol were decreased 
at 12 months of diet in the initial, repeat cross-sectional study. In contrast, total cholesterol 
was not different between mild and severe CAD groups in the 11-month diet study (data not 
shown).
Coronary artery disease (CAD) severity increases during prolonged MetS duration
Analysis of IVUS still-frames revealed increased coronary artery plaque burden MetS swine 
with time on atherogenic diet (Fig. 1D), but did not significantly increase until 12 months on 
diet. Percent wall coverage increased early in MetS-induced CAD, plateauing later (Fig. 1D; 
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solid line), indicating that atherosclerotic plaques expand around the circumference of the 
artery prior to encroachment upon the lumen. These data support our statement that percent 
wall coverage is a strong tool for quantification of early intimal CAD prior to the stage of 
more intimal plaque burden. These quantification methods suggest that swine on 6–9 months 
of atherogenic diet present with “early stage” CAD (representative IVUS still frame in Fig. 
1B), whereas 12 months on atherogenic diet results in “late stage” CAD (representative still 
frame in Fig. 1C).
Coronary smooth muscle Ca2+ responses to depolarization are biphasically altered during 
disease progression
Fura-2/AM assessment of intracellular Ca2+ handling in response to depolarization revealed 
a biphasic pattern in CSM from swine with MetS, in which responses were heightened in 
“early state” CAD, followed by dampened responses in “late stage” CAD. Fig. 2A provides 
a representative tracing to demonstrate the experimental protocol. CSM from swine with 
“early stage” CAD after nine months of atherogenic feeding demonstrated greater Ca2+ 
influx through voltage-gated Ca2+ channels (VGCC) after activation by K+ (80 mmol/L; 
Green shading; Fig. 2A) compared to cells from age-matched lean swine as quantified by 
area under the curve. This increased VGCC activation was absent in CSM from swine with 
“late stage” CAD (Fig. 2B).
Coronary artery responses to depolarization are biphasically altered during disease 
progression
Functional assessment of coronary rings from lean pigs revealed no effect of age on tension 
development to KCl (20 mM) (Fig. 2C; black bars). Rings from swine with MetS revealed a 
biphasic change in tension development to 20 mM KCl as CAD progressed (Fig. 2C; white 
bars). When compared to age-matched leans, rings from swine with “early stage” CAD after 
9 months of atherogenic feeding developed significantly more tension to KCl (20 mM). 
Following 12 months of atherogenic diet feeding, tension development dramatically 
decreases below that of rings from lean age-matched swine (Fig. 2C).
Sarcoplasmic reticulum Ca2+ store capacity is altered during CAD progression
Release of the SR store with caffeine (5 mmol/L)-triggered activation of ryanodine receptors 
is observed as a transient, robust increase in cytosolic [Ca2+] (blue arrow; Fig. 2A). This 
transient increase was significantly greater in CSM from swine with “early stage” CAD 
compared to CSM from age-matched lean swine. As observed with depolarization 
responses, this increased Ca2+ signal in CSM from swine with “early stage” CAD was 
absent in CSM from swine with “late stage” CAD (Fig. 2D).
Recovery of cytosolic [Ca2+] following SR Ca2+ store release is biphasically altered during 
CAD progression
Finally, Ca2+ buffering impairment along with simultaneously store-operated Ca2+ influx 
was assessed after SR store depletion. This is observed as a sustained Ca2+ signal above 
baseline levels following SR Ca2+ store depletion with caffeine (red arrow; Fig. 2A). While 
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this revealed the same pattern of Ca2+ alterations during the time course of CAD 
progression, no significant changes from age-matched lean swine were observed (Fig. 2E).
Plaque burden and collagen content are increased with CAD severity
Arteries with greater than 30% plaque burden as assessed by IVUS were classified as having 
“severe” CAD, while arteries with less than 30% plaque burden were classified as having 
“mild” CAD. To further classify disease severity for more detailed analysis of plaque 
composition, histological analysis was performed. See lumen (L), intima (I), and media (M) 
layers labeled in Fig. 3A–C. Plaque burden in the “severe CAD” group was increased 
compared to that in the “mild CAD” group (Fig. 3G). An additional measure of intimal 
plaque growth is obtained when the intimal/medial area ratio (I/M) is assessed. I/M was 
significantly increased in severe CAD, compared to mild (Fig. 3H). Further, to assess 
progression of plaque fibrosis, collagen content within the plaque was examined and was 
increased ~30% in severe disease, compared to mild (Fig. 3I). Medial collagen content 
trended toward increase with severe CAD, but this was not significant (Fig. 3J; p=0.08).
Sarcoplasmic reticulum Ca2+ handling is altered with CAD severity
To examine steady-state SR [Ca2+], the SR Ca2+ store was released with caffeine (5 mmol/l) 
in the absence of extracellular Ca2+ (See Fig. 4A for representative tracing/experimental 
protocol; “Caf-sensitive SR Ca2+ store”; bi-directional arrow) and the transient increase in 
cytosolic [Ca2+] was measured. In CSM isolated from arterial segments with mild CAD a 
dramatic increase in caffeine-sensitive steady-state SR [Ca2+] was observed (Fig. 4B). In 
contrast, CSM isolated from plaques of arteries with severe CAD showed depletion of the 
caffeine-sensitive steady-state SR [Ca2+] compared to CSM isolated from both healthy and 
mild CAD swine. Following an increase in cytosolic [Ca2+] resulting from caffeine 
stimulation, a number of extrusion/buffering mechanisms are employed to restore cytosolic 
[Ca2+]. SERCA buffering activity is assessed by measuring the cytosolic [Ca2+] undershoot 
below baseline levels during recovery from caffeine stimulation (see Fig. 4A; “SERCA 
Activity”; downward arrow). The cytosolic [Ca2+] undershoot (SERCA activity) was 
increased in mild CAD and was dramatically decreased in CSM of arterial segments from 
severe CAD (Fig. 4C).
To provide an intra-arterial comparison, intracellular Ca2+ regulation in CSM harvested 
specifically from the intima (plaque) region was compared to CSM from the wall (media) of 
arteries with severe CAD. The caffeine-sensitive steady-state SR Ca2+ store was depleted in 
CSM from intima (plaque) compared to CSM from the artery wall (media) (Fig. 4D). 
Correspondingly, when CSM from the intima (plaque) was compared with the adjacent 
artery wall (media), plaque cells demonstrated a decreased undershoot, i.e. decreased 
SERCA activity (Fig. 4E).
L-type voltage-gated channel function is altered with CAD severity
To further and more specifically assess VGCC function, Ba2+-containing depolarizing 
solution with low Na+ was employed. Ca2+ influx through VGCC immediately triggers 
activation of Ca2+ extrusion and buffering mechanisms, which makes direct assessment of 
VGCC activity difficult. Fura-2 binds Ba2+ with similar affinity as to Ca2+. Substitution of 
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Ca2+ with Ba2+ allows Ba2+ entry through VGCC upon depolarization. Ba2+ is not buffered 
by SERCA or transported by the plasma membrane Ca2+ ATPase. Low extracellular Na+ 
inhibits Na+/Ca2+ exchange, preventing Ba2+ extrusion by this pathway, thereby providing a 
pure measure of VGCC function. For a representative tracing and experimental protocol, see 
Fig. 4F.
The rate of Ba2+ entry was assessed as the slope of the rise in the F340/F380 signal following 
depolarization. Rate of Ba2+ entry through VGCCs was dramatically increased in CSM from 
swine with mild CAD compared to Healthy and severe CAD (Fig. 4G). We also examined 
rate of Ba2+ entry following depolarization in the arterial wall (media) adjacent to the 
excised intima (plaque). VGCC activity was not different in CSM from plaques compared to 
CSM in their adjacent arterial media (Fig. 4H). The Healthy, Mild CAD, and Severe CAD 
histology with schematic illustrations of normal SR, increased SR, and decreased SR Ca2+ 
stores, respectively, are shown in Fig. 4I. The figure shows the proposed changes in Ca2+ 
handling associated with CSM phenotypic modulation during CAD progression.
Cell proliferation declines with CAD severity
To determine whether proliferation follows Ca2+ handling patterns, Ki-67 expression was 
measured as an index of proliferative activity within coronary artery sections (Fig. 5A–D). 
The number of proliferative cells within the intimal region of coronary arteries with severe 
CAD was dramatically reduced, compared to arteries with mild CAD (Fig 5E).
DISCUSSION
There is a paucity of literature on a time course analysis of the connection between MetS-
induced CAD and CSM Ca2+ regulation. This study steps into the gap and provides insight 
into the transitory, biphasic nature of CSM Ca2+ regulation during the progression of CAD. 
Using in vivo intravascular ultrasound imaging we showed increased circumferential 
neointimal wall coverage in early CAD and more severe increased plaque burden in late 
CAD. The power of IVUS is that after the highly sensitive analysis of CAD progression the 
arteries are viable for interrogation of cellular Ca2+ signaling. We found increased Ca2+ 
influx and Ca2+ release and buffering by the sarcoplasmic reticulum in early CAD and a 
surprising reversal of these Ca2+ signaling events in more severe, late state CAD. By 
separating overt plaques away from medial CSM in the artery wall, we provide novel insight 
into heterogeneity of intracellular Ca2+ regulation in the different regions of severely 
diseased arteries.
This clarity is important because there has been confusion regarding differences in 
intracellular Ca2+ regulation observed in several studies of CAD. For instance, Witczak et al.
19
 and Hill et al.21 reported increases in SERCA expression and function. Witczak et al. and 
others37 also demonstrated decreases in VGCC function with disease. However, Neeb et al.
22
 demonstrated a decrease in SERCA function with disease, and several studies20, 38, 39 
reported an increase in VGCC function with disease. One possible explanation for the 
apparent discrepancy in the data is duration of diet and/or severity of disease. Indeed, diet 
duration is different in each of these studies, causing differences in disease severity. An 
additional factor in these discrepancies may be the swine model. Witczak19 and Hill21 
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utilized diabetic dyslipidemic Yucatan swine that had no primary insulin resistance, while 
Berwick20 utilized MetS Ossabaw swine with primary insulin resistance, hypertension, and 
increased aldosterone as major characteristics. Neeb22 used both Ossabaw and Yucatan 
swine. Indeed, Neeb’s work highlights model differences in SERCA function,22 
underscoring the need for time-dependent studies in the same model. Specific components 
of the Ossabaw swine model that may contribute to differences in Ca2+ regulation include 
primary insulin resistance and increased aldosterone40. The current study provides a repeat 
cross-sectional examination of intracellular Ca2+ regulation in MetS Ossabaw swine during 
CAD progression, reconciling the discrepant results in the reports mentioned above.
Here, we report that function of VGCC and SERCA is enhanced with early, mild CAD and 
that these functions decrease with increased CAD severity. These data explain, in part, the 
discrepancies in the reports mentioned above. During early, MetS-induced CAD, VGCC 
activity is increased, as observed by Berwick, et al.20 At the same time, SERCA activity is 
increased, as observed by Witczak et al19. As MetS and CAD progress, however, VGCC and 
SERCA function are greatly diminished, which corresponds to the findings of Witczak19 and 
Neeb22. This decrease in VGCC and SERCA function appears to occur concurrently with a 
reduction in cell proliferation, as measured by Ki-67 expression. Future studies will seek to 
determine whether these phenomena are causally linked.
Interestingly, in the repeat cross-sectional study, plasma triglycerides and total cholesterol 
were decreased after 12 months on atherogenic diet vs. 6 and 9 months, suggesting that 
plasma cholesterol could play a role in Ca2+ handling differences observed over CAD 
progression. This is unlikely, however, because the plasma cholesterol at 12 months was still 
increased ~4-fold above that of healthy lean pigs. Further, in the eleven month subset of 
swine used for analysis of Ca2+ handling in atherosclerotic plaque vs. media, total plasma 
cholesterol was not different in the mild vs. severe CAD groups, yet the decreases in 
SERCA and VGCC function persisted. These data suggest that the plasma cholesterol 
decrease in the repeat cross-sectional study did not explain the decrease in CSM Ca2+ 
handling in late CAD.
Additionally, this study provides new insight on intracellular Ca2+ regulation within 
atherosclerotic plaque. In the repeat cross-sectional study, CSM isolated from coronary 
arteries with “late” CAD were a mixed population of cells from the arterial wall and cells 
from the plaque. Here, for the first time isolating atherosclerotic plaques away from the 
artery wall, we provided a close-up look at CSM Ca2+ regulation within a plaque. Fig. 4D, 
E, and H provide strong evidence that SR Ca2+ handling is decreased in the intima (plaques) 
of arteries with severe CAD, compared to its adjacent wall (media). This finding prompts 
several questions: 1) Does a shift in Ca2+ regulation within atherosclerotic plaques signal a 
shift in the dominant cell phenotype within an atherosclerotic plaque? 2) If so, can 
intracellular Ca2+ handling provide insight regarding plaque stability and phenotypic 
modulation? These questions are beyond the scope of the current project, but are interesting 
areas of future investigation.
Together, the data in this report provide a much needed study of CAD progression in 
metabolic syndrome, providing insight on IVUS determinants of CAD severity and 
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histological analysis of cellular components of CAD progression. The study also highlights 
the need for additional studies to further solidify causal links between intracellular Ca2+ 
regulation, CSM proliferation, and alterations in atherosclerotic plaque morphology during 
CAD progression.
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Highlights
• Atherosclerotic coronary artery disease (CAD) progresses around the 
circumference of the artery, followed by encroachment on the lumen.
• Sarco-endoplasmic reticulum ATPase (SERCA) activity is increased in early, 
mild CAD and decreased in late, severe CAD, and this is correlated with an 
increased sarcoplasmic reticulum Ca2+ store.
• Voltage-gated Ca2+ channel (VGCC) function is increased in early, mild CAD.
• Increased SERCA and VGCC function are associated with elevated proliferation 
in early, mild CAD.
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Fig. 1. Intravascular ultrasound imaging of coronary arteries with varying stages of coronary 
artery disease in the repeat cross-sectional study
(A) Cross-sectional view of a coronary artery from a lean pig. (B) Cross-sectional view of a 
coronary artery from a MetS pig with “early stage” CAD. Internal elastic lamina = yellow 
dotted line; lumen = red dashed line. (C) Cross-sectional view of a coronary artery from a 
MetS pig with “late stage” CAD. Distance between blue dots in A–C is 1 mm. (D) Wall 
coverage significantly increases in “early stage” CAD (0–9 months). Plaque burden does not 
increase until “late stage” CAD (>9 months). (lean= 4 pigs, MetS 6 months= 5 pigs, MetS 9 
months= 5 pigs, MetS 12 months= 7 pigs). (E) Right anterior oblique coronary angiogram 
indicating lumen stenosis (arrow) in the left anterior descending artery. (F) IVUS still frame 
which corresponds to lumen stenosis in panel E.
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Fig. 2. Intracellular Ca2+ signaling is biphasically altered in coronary smooth muscle cells during 
CAD progression in the repeat cross-sectional study
(A) Representative tracing of CSM cytosolic Ca2+ flux. Labels indicate solution changes 
through superfusion chamber with duration shown by the horizontal lines. VGCC = voltage-
gated Ca2+ channel; Caf = caffeine; green area under the curve = Ca2+ after 80 mM K+ 
membrane depolarization; blue double-headed arrow = SR Ca2+ store release; red double-
headed arrow = delayed recovery to basal Ca2+ levels due to impaired Ca2+ buffering and 
store-operated influx. (B) 9 month duration of diet results in elevated Ca2+ influx following 
depolarization, compared to 6 and 12 months (dashed lines indicating significant 
differences) and to age-matched lean pigs (solid lines indicating significant differences). (C) 
Tension development to KCl (20 mM) in isolated coronary rings paralleled the changes in K 
depolarization-induced Ca2+ in panel B. (D) SR Ca2+ store release is elevated at 9 months 
on atherogenic diet, compared to 6 and 12 months (dashed lines indicating significant 
differences), and to age-matched lean pigs. € 9 months of atherogenic diet results in an 
increase in sustained Ca2+ signal, compared to 6 and 12 months, but not to age-matched 
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leans. (Lean = 9 pigs, cells = 60; MetS 6 months = 6 pigs, cells = 56; MetS 9 months = 7 
pigs, cells = 68; MetS 12 months = 9 pigs, cells = 92)
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Fig. 3. Histological assessment of mild and severe CAD and collagen deposition
(A–C) Verhoeff-Van Giesen staining of elastin in a coronary arterial ring in lean (A), mild 
CAD (IVUS-detected plaque burden < 30%) (B), and severe CAD (IVUS-detected plaque 
burden > 30%) (C). L = Lumen; M = Media (Wall). I = Intima (plaque). Black arrows 
indicate the internal elastic lamina adjacent to early atherosclerotic lesion. (D – F) 
Picrosirius red staining of collagen deposition in lean (D), mild CAD (E), and severe CAD 
(F) coronary arterial rings. (G) % plaque burden is increased with severe CAD. (H) Intima/
media ratio is increased with severe CAD. (I) Intimal collagen deposition is increased in 
severe CAD. (J) Medial collagen deposition demonstrates a trend (p=0.08) toward increase 
in severe CAD. (Mild CAD = 9 pigs; Severe CAD = 5 pigs)*p <0.05.
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Fig. 4. Intracellular Ca2+ handling is biphasically altered with CAD severity
(A) Experimental protocol for panels B–E. (B) The caffeine-sensitive steady-state SR store 
is increased in mild CAD compared to both healthy lean and severe CAD. (C) The 
undershoot of cytosolic Ca2+ during recovery following removal of caffeine (SERCA 
activity) is increased in mild CAD compared to both healthy lean and severe CAD. (D) 
When compared with CSM isolated from the adjacent arterial media (wall), intimal (plaque) 
CSM display decreased caffeine-releasable steady-state SR Ca2+ store. (E) When compared 
with CSM isolated from the adjacent arterial media (wall), intimal (plaque) CSM display 
decreased SERCA activity. (Healthy = 6 pigs, cells = 67; Mild CAD = 9 pigs, cells = 156; 
Plaque = 5 pigs, cells = 29; Wall = 5 pigs, cells = 27). (F) Experimental protocol for panels 
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G–H. G. Rate of Ba2+ influx following depolarization is increased in CSM from mild CAD 
vs. Healthy and Severe CAD. (H) When compared to CSM from the media (wall) adjacent 
to the plaque, intimal (plaque) cells do not demonstrate a difference in Ba2+ influx. (Healthy 
= 6 pigs, cells = 72; Mild CAD = 9 pigs, cells = 151; Plaque = 5 pigs, cells = 25; Wall = 5 
pigs, cells = 42). (I) Schematic depicting proposed changes in Ca2+ handling associated with 
CSM phenotypic modulation during CAD progression. Blue circles = Ca2+.
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Fig. 5. Cellular proliferation is decreased in severe CAD
(A) Arterial ring from swine with mild CAD, interrogated with an antibody against Ki-67. 
(B) Arterial ring from swine with severe CAD, interrogated with an antibody against Ki-67. 
(C–D) Zoomed-in regions of rings in panels A and B. Black arrows indicate positive Ki-67 
staining. Diamond arrows indicate negative Ki-67 stain. (E) Ki-67 expression is decreased in 
severe CAD. (Mild CAD = 8 pigs; Severe CAD = 5 pigs).
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